David Lewis Analyst Performance

David Lewis is a stock analyst at Morgan Stanley focused in the medical sector, covering 16 publicly traded companies. Over the past year, David Lewis has issued 2 stock ratings, including and hold recommendations. While full access to David Lewis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Lewis' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

55 Last 10 Years

Buy Recommendations

61.82% 34 Buy Ratings

Companies Covered

16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	61.8%	34 ratings
Hold	29.1%	16 ratings
Sell	9.1%	5 ratings

Out of 55 total stock ratings issued by David Lewis at Morgan Stanley, the majority (61.8%) have been Buy recommendations, followed by 29.1% Hold and 9.1% Sell.

Best & Worst Calls

• Best Call

  000.0%

  NVRO

  Aug 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  ZBH

  Feb 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	75.0% of companies on NYSE	12 companies
NASDAQ	25.0% of companies on NASDAQ	4 companies

David Lewis, an analyst at Morgan Stanley, currently covers 16 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 15 companies	93.8%
	Miscellaneous 1 company	6.3%

David Lewis of Morgan Stanley specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 6 companies	37.5%
SURGICAL & MEDICAL INSTRUMENTS 4 companies	25.0%
MED INSTRUMENTS 3 companies	18.8%
LARGE CAP PHARMA 1 company	6.3%
Miscellaneous 1 company	6.3%
MED/DENTAL - SUPP 1 company	6.3%

David Lewis' Ratings History at Morgan Stanley

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
ABT Abbott Laboratories	7/15/2025	Boost Price Target	$132.05	$137.00	Equal Weight	$0.00 00.00% ROI
ABT Abbott Laboratories	4/17/2025	Boost Price Target	$131.37	$127.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.